Mr. Speaker, this evening we will have an opportunity to move one step closer to giving millions of people in developing countries access to medicines. Grandmothers associations, religious leaders, international health experts, the generic drug industry and even the brand name drug industry believe that this bill should be examined in committee. Excuses citing intellectual property and the WTO simply do not hold water.
This evening, will the Conservatives vote for or against the—